[1] Chen J, Budoff M J, Reilly M P, et al. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease[J]. JAMA Cardiol,2017,2(6):635-643.
[2] Honda H, Hosaka N, Ganz T, et al. Iron Metabolism in Chronic Kidney Disease Patients[J]. Contrib Nephrol,2019,198:103-111.
[3] Kuscuoglu D, Janciauskiene S, Hamesch K, et al. Liver - master and servant of serum proteome[J]. J Hepatol,2018,69(2):512-524.
[4] Ruiz-Jaramillo Mde L, Guízar-Mendoza JM, Amador-Licona N, et al. Iron overload as cardiovascular risk factor inchildren and adolescents with renal disease[J]. Nephrol Dial Transplant,2011,26(10):3268-3273.
[5] Chen Y, Zhao X, Wu H. Arterial Stiffness: A Focus on Vascular Calcification and Its Link to Bone Mineralization[J]. Arterioscler Thromb Vasc Biol,2020,40(5):1078-1093.
[6] Adeney KL, Siscovick DS, Ix JH, et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD[J]. J Am Soc Nephrol,2009,20(2):381-387.
[7] 吴茜茜,王德光,张森,等.慢性肾脏病 3~5 期非透析患者中性粒细胞与淋巴细胞比值与腹主动脉钙化的相关性研究[J].安徽医科大学报,2019,54(07):1141-1145.
[8] Cornelissen A, Guo L, Sakamoto A, et al. New insights into the role of iron in inflammation and atherosclerosis[J]. EBioMedicine,2019,47(9):598-606.
[9] Xu S.Iron and Atherosclerosis: The Link Revisited[J]. Trends Mol Med,2019,25(8):659-661.
[10] Kuo KL, Hung SC, Lee TS, et al. Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD[J]. J Am Soc Nephrol, 2014,25(11): 2596-2606.
[11] Shi Y, Zhou L, Huang L H, et al. Plasma ferritin levels, genetic variations in HFE gene, and coronary heart disease in Chinese: a case-control study[J]. Atherosclerosis,2011,218(2):386-390.
[12] Gkouvatsos K, Papanikolaou G, Pantopoulos K. Regulation of iron transport and the role of transferrin[J]. Biochim Biophys Acta,2012,1820(3):188-202.
[13] Kibel A, Belovari T, Drenjancevi?-Peri? I. The role of transferrin in atherosclerosis[J]. Med Hypotheses,2008,70(4):793-797.
[14] Besarab A, Coyne DW. Iron supplementation to treat anemia in patients with chronic kidney disease[J]. Nat Rev Nephrol,2010,6(12):699-710.
[15] 魏萌,魏丽敏,王萌,等.维持性血液透析患者血管钙化的危险因素分析[J]. 中国血液净化,2020,19(11):742-746.
[16] Kotur-Stevuljevic J, Simic-Ogrizovic S, Dopsaj V, et al. A hazardous link between malnutrition, inflammation and oxidative stress in renal patients[J]. Clin Biochem,2012,45(15):1202-1205.
[17] Breuer W, Hershko C, Cabantchik ZI. The importance of non-transferrin bound iron in disorders of iron metabolism[J]. Transfus Sci,2000,23(3):185-192.
[18] Vinchi F, Porto G, Simmelbauer A, et al. Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction[J]. Eur Heart J,2020,41(28):2681-2695.
[19] Hilton RJ, Seare MC, Andros ND, et al. Phosphate inhibits in vitro Fe3 loading into transferrin by forming a soluble Fe(III)-phosphate complex: a potential non-transferrin bound iron species[J]. J Inorg Biochem,2012,110:1-7. |